Literature DB >> 10197588

Developmental basis of retinal-specific induction of cancer by RB mutation.

B L Gallie1, C Campbell, H Devlin, A Duckett, J A Squire.   

Abstract

Understanding why children with RB mutations specifically develop retinoblastoma will contribute to the understanding of the fundamental principles of cancer. Only a subset of developing retinal cells are at risk for developing cancer when RB is mutant because rod photoreceptor and bipolar cells never normally express RB. Retinoblastomas are observed to arise commonly in the inner nuclear layer, where they can show features attributed to outer nuclear layer cells (photoreceptors). The best-studied function of RB is control of the cell cycle, and the usual tissue consequence of loss of RB is apoptosis. Perhaps the specificity of RB mutation for retinal cancer resides in the dependency of this tissue on programmed cell death to achieve a precise architecture of individual types of interconnecting neurons. The additional mutations that are present in all retinoblastoma, such as the i(6p) marker chromosome, may interrupt signals that normally would induce apoptosis when RB is absent. A combination of loss of cell cycle control and loss of signals that delete extra cells would result in retinoblastoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197588

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system.

Authors:  D MacPherson; J Sage; D Crowley; A Trumpp; R T Bronson; T Jacks
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

2.  Tumor-associated retinal astrocytes promote retinoblastoma cell proliferation through production of IGFBP-5.

Authors:  Xiaoliang L Xu; Thomas C Lee; Nneka Offor; Christine Cheng; Aihong Liu; Yuqiang Fang; Suresh C Jhanwar; David H Abramson; David Cobrinik
Journal:  Am J Pathol       Date:  2010-05-27       Impact factor: 4.307

3.  Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA.

Authors:  Gabriella Livide; Maria Carmela Epistolato; Mariangela Amenduni; Vittoria Disciglio; Annabella Marozza; Maria Antonietta Mencarelli; Paolo Toti; Stefano Lazzi; Theodora Hadjistilianou; Sonia De Francesco; Alfonso D'Ambrosio; Alessandra Renieri; Francesca Ariani
Journal:  Pathol Oncol Res       Date:  2012-01-26       Impact factor: 3.201

4.  New RB1 oncogenic mutations and intronic polymorphisms in Serbian retinoblastoma patients: genetic counseling implications.

Authors:  Milica Kontic; Iciar Palacios; Ángelo Gámez; Isabel Camino; Zoran Latkovic; Dejan Rasic; Vera Krstic; Vera Bunjevacki; Javier Alonso; Ángel Pestaña
Journal:  J Hum Genet       Date:  2006-09-14       Impact factor: 3.172

Review 5.  Chromosome 6p amplification and cancer progression.

Authors:  Gda C Santos; M Zielenska; M Prasad; J A Squire
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

6.  Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.

Authors:  Armin R Afshar; Melike Pekmezci; Michele M Bloomer; Nicola J Cadenas; Meredith Stevers; Anuradha Banerjee; Ritu Roy; Adam B Olshen; Jessica Van Ziffle; Courtney Onodera; W Patrick Devine; James P Grenert; Boris C Bastian; David A Solomon; Bertil E Damato
Journal:  Ophthalmology       Date:  2019-12-12       Impact factor: 12.079

7.  Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130.

Authors:  Jan-Hermen Dannenberg; Leontine Schuijff; Marleen Dekker; Martin van der Valk; Hein te Riele
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

8.  Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death.

Authors:  Mellone N Marchong; Christine Yurkowski; Clement Ma; Clarellen Spencer; Sanja Pajovic; Brenda L Gallie
Journal:  PLoS Genet       Date:  2010-04-22       Impact factor: 5.917

9.  Molecular karyotype of sporadic unilateral retinoblastoma tumors.

Authors:  Arupa Ganguly; Kim E Nichols; Gregory Grant; Eric Rappaport; Carol Shields
Journal:  Retina       Date:  2009 Jul-Aug       Impact factor: 4.256

10.  Full-field electroretinography under general anesthesia in retinoblastoma.

Authors:  Ramya Sachidanandam; S Krishnakumar; Lingam Gopal; Joan M O'Brien; Vikas Khetan; Parveen Sen
Journal:  Doc Ophthalmol       Date:  2013-01-04       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.